Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Immunopharmacology and Immunotoxicology
|
March 7, 2012
Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy
S M L Aversa, S Zanon, D Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
A Brunello, U Basso, C Pogliani, et al.
Journal of the National Cancer Institute
|
February 16, 1994
Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo
A Paccagnella, A Orlando, C Marchiori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study
A A Brandes, U Basso, F Vastola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group
E Bajetta, N Zilembo, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
S Cresta, G Grasselli, M Mansutti, et al.
British Journal of Cancer
|
September 8, 2012
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer
E Rossi, M Fassan, M Aieta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Immunopharmacology and Immunotoxicology
|
March 7, 2012
Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy
S M L Aversa, S Zanon, D Marino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
A Brunello, U Basso, C Pogliani, et al.
Journal of the National Cancer Institute
|
February 16, 1994
Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo
A Paccagnella, A Orlando, C Marchiori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2003
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study
A A Brandes, U Basso, F Vastola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group
E Bajetta, N Zilembo, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
S Cresta, G Grasselli, M Mansutti, et al.
British Journal of Cancer
|
September 8, 2012
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer
E Rossi, M Fassan, M Aieta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 4